We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$50.7M
AUM Growth
-$91.4M
Cap. Flow
-$87.1M
Cap. Flow %
-171.69%
Top 10 Hldgs %
89.73%
Holding
46
New
–
Increased
–
Reduced
17
Closed
27

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$12M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$5.26M
3
ARRY
Array Biopharma Inc
ARRY
+$4.01M
4
IOVA icon
Iovance Biotherapeutics
IOVA
+$3.21M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$3.16M

Sector Composition

Rank Sector Weight
1 Financials 61.49%
2 Healthcare 34.13%
3 Industrials 1.88%
4 Energy 0.67%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
26
DELISTED
Blueprint Medicines
BPMC
– –
-27,551
Closed -$2.6M
C icon
27
Citigroup
C
$222B
– –
-28,938
Closed -$2.03M
CBRE icon
28
CBRE Group
CBRE
$40.8B
– –
-39,052
Closed -$2M
FOLD
29
DELISTED
Amicus Therapeutics
FOLD
– –
-192,533
Closed -$2.4M
HD icon
30
Home Depot
HD
$332B
– –
-1,819
Closed -$378K
INCY icon
31
Incyte
INCY
$23.5B
– –
-28,714
Closed -$2.44M
IOVA icon
32
Iovance Biotherapeutics
IOVA
$2.23B
– –
-131,041
Closed -$3.21M
JD icon
33
JD.com
JD
$40.8B
– –
-397,528
Closed -$12M
KKR icon
34
KKR & Co
KKR
$89.2B
– –
-76,943
Closed -$1.94M
MDGL icon
35
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-23,131
Closed -$2.42M
MS icon
36
Morgan Stanley
MS
$337B
– –
-43,300
Closed -$1.9M
NBIX icon
37
Neurocrine Biosciences
NBIX
$17.7B
– –
-29,020
Closed -$2.45M
SLM icon
38
SLM Corp
SLM
$4.57B
– –
-190,827
Closed -$1.85M
STX icon
39
Seagate
STX
$193B
– –
-42,275
Closed -$1.99M
TRN icon
40
Trinity Industries
TRN
$2.97B
– –
-90,599
Closed -$1.88M
ONC
41
BeOne Medicines Ltd
ONC
$33.8B
– –
-17,807
Closed -$2.21M
MRTX
42
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-30,680
Closed -$3.16M
SGEN
43
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-33,593
Closed -$2.33M
GBT
44
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-39,349
Closed -$2.07M
ALXN
45
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-18,235
Closed -$2.39M
ARRY
46
DELISTED
Array Biopharma Inc
ARRY
– –
-86,567
Closed -$4.01M
1
2

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q3 2019 Portfolio in Review

As of Q3 2019, Emory University held 46 positions worth $50.7M, down 64% from $142M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Emory University withdrew a net $87.1M in Q3 2019, closing 27 positions and reducing 17 holdings. Its most notable exit was JD.com, an estimated $12M position sold in full.

By sector, the portfolio is most concentrated in Financials at 61% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

  • Emory University's biggest Q3 2019 reduction was Berkshire Hathaway Class A, cutting an estimated $5.26M.
  • Emory University fully exited JD.com in Q3 2019, selling an estimated $12M.
  • Emory University's ten largest holdings make up 90% of its $50.7M portfolio in Q3 2019.
  • Emory University opened 0 new positions and closed 27 in Q3 2019.
  • Emory University's portfolio value fell 64% quarter-over-quarter to $50.7M.

Based on Emory University's 13F filing for Q3 2019, filed 14 Nov 2019.